CD4 and diabetes mellitus: In contrast to the results seen with the CD8+ T cells, co-transfer of the e-B cells expressing the 2.5HIP/I-Ag7 construct, together with pre-activated pathogenic BDC2.5 CD4+ T cells, completely protected the NOD.Scid recipient mice from developing diabetes, regardless of which subset of B cells was used (Figure 8).